<unk>  is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.<unk>  may be administered in combination with other antidiabetic drugs; dose of concomitant insulin or sulfonylurea may need to be reduced.<unk>  (Wegovy) is also indicated as an adjunct to diet and exercise for long-term weight management in adults with obesity (initial body mass index (BMI) ≥ 30 kg/m2) or overweight (initial BMI ≥ 27 kg/m2) with at least one weight-related comorbidity.
Semaglutide
Albiglutide
Teduglutide
Dulaglutide
Liraglutide
Linagliptin
Exenatide
Saxagliptin